In conclusion, gene therapy offers a transformative potential for the diagnosis and treatment of DSD.
First-pass extracted concept
gene therapy for disorders of sex development
Candidate: concept label1 source documents3 linked claims
Live refresh every 5sNext refresh in 5s
Aliases
DSD gene therapy
Evidence Snippets
Supporting Sources
Linked Claims
The review describes CRISPR/Cas9, TALENs, ZFNs, and viral vector-mediated delivery systems as gene therapy strategies targeting DSD-relevant loci.
Quoted textsource-backed
It further elaborates on gene therapy strategies targeting these loci through the use of CRISPR/Cas9, TALENs, ZFNs, and viral vector-mediated delivery systems.
Current international bioethics frameworks recommend limiting DSD gene-therapy clinical applications to somatic cells under stringent regulatory oversight.
Quoted textsource-backed
Current international bioethics frameworks urge caution and recommend limiting clinical applications to somatic cells under stringent regulatory oversight.
Current gene therapy approaches for DSD face technical challenges including off-target effects, immunogenicity of viral vectors or editing enzymes, and instability of long-term transgene expression.
Quoted textsource-backed
Despite this progress, current gene therapy approaches still face considerable technical challenges, such as off-target effects, immunogenicity of viral vectors or editing enzymes, and long-term transgene expression instability.